GB1159490A - Improvements in Acylated Steroids - Google Patents
Improvements in Acylated SteroidsInfo
- Publication number
- GB1159490A GB1159490A GB30019/68A GB3001968A GB1159490A GB 1159490 A GB1159490 A GB 1159490A GB 30019/68 A GB30019/68 A GB 30019/68A GB 3001968 A GB3001968 A GB 3001968A GB 1159490 A GB1159490 A GB 1159490A
- Authority
- GB
- United Kingdom
- Prior art keywords
- compounds
- fluorine
- hydroxy
- hydroxyprogesterone
- progesterone
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 150000003431 steroids Chemical class 0.000 title abstract 2
- 150000001875 compounds Chemical class 0.000 abstract 6
- PXGOKWXKJXAPGV-UHFFFAOYSA-N Fluorine Chemical compound FF PXGOKWXKJXAPGV-UHFFFAOYSA-N 0.000 abstract 4
- 229910052731 fluorine Inorganic materials 0.000 abstract 4
- 239000011737 fluorine Substances 0.000 abstract 4
- DBPWSSGDRRHUNT-UHFFFAOYSA-N 17alpha-hydroxy progesterone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(=O)C)(O)C1(C)CC2 DBPWSSGDRRHUNT-UHFFFAOYSA-N 0.000 abstract 3
- ZAMOUSCENKQFHK-UHFFFAOYSA-N Chlorine atom Chemical compound [Cl] ZAMOUSCENKQFHK-UHFFFAOYSA-N 0.000 abstract 3
- 229910052801 chlorine Inorganic materials 0.000 abstract 3
- 239000000460 chlorine Substances 0.000 abstract 3
- 238000006356 dehydrogenation reaction Methods 0.000 abstract 3
- 239000001257 hydrogen Substances 0.000 abstract 3
- 229910052739 hydrogen Inorganic materials 0.000 abstract 3
- 229950000801 hydroxyprogesterone caproate Drugs 0.000 abstract 3
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 abstract 3
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 abstract 2
- 125000004423 acyloxy group Chemical group 0.000 abstract 2
- 125000000217 alkyl group Chemical group 0.000 abstract 2
- KRVSOGSZCMJSLX-UHFFFAOYSA-L chromic acid Substances O[Cr](O)(=O)=O KRVSOGSZCMJSLX-UHFFFAOYSA-L 0.000 abstract 2
- AWJWCTOOIBYHON-UHFFFAOYSA-N furo[3,4-b]pyrazine-5,7-dione Chemical compound C1=CN=C2C(=O)OC(=O)C2=N1 AWJWCTOOIBYHON-UHFFFAOYSA-N 0.000 abstract 2
- 150000002431 hydrogen Chemical class 0.000 abstract 2
- 150000002500 ions Chemical class 0.000 abstract 2
- 229920006395 saturated elastomer Polymers 0.000 abstract 2
- KQZSMOGWYFPKCH-UJPCIWJBSA-N (8s,9s,10r,11s,13s,14s,17r)-17-acetyl-11,17-dihydroxy-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6h-cyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)C[C@@H]2O KQZSMOGWYFPKCH-UJPCIWJBSA-N 0.000 abstract 1
- DBPWSSGDRRHUNT-CEGNMAFCSA-N 17α-hydroxyprogesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2 DBPWSSGDRRHUNT-CEGNMAFCSA-N 0.000 abstract 1
- HZNVUJQVZSTENZ-UHFFFAOYSA-N 2,3-dichloro-5,6-dicyano-1,4-benzoquinone Chemical compound ClC1=C(Cl)C(=O)C(C#N)=C(C#N)C1=O HZNVUJQVZSTENZ-UHFFFAOYSA-N 0.000 abstract 1
- PUKLDDOGISCFCP-JSQCKWNTSA-N 21-Deoxycortisone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)C)(O)[C@@]1(C)CC2=O PUKLDDOGISCFCP-JSQCKWNTSA-N 0.000 abstract 1
- 241000122824 Aspergillus ochraceus Species 0.000 abstract 1
- 241000223208 Curvularia Species 0.000 abstract 1
- 102000004190 Enzymes Human genes 0.000 abstract 1
- 108090000790 Enzymes Proteins 0.000 abstract 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 abstract 1
- 229910010199 LiAl Inorganic materials 0.000 abstract 1
- 241000193386 Lysinibacillus sphaericus Species 0.000 abstract 1
- 241000203720 Pimelobacter simplex Species 0.000 abstract 1
- 241000215410 Trichothecium roseum Species 0.000 abstract 1
- 230000010933 acylation Effects 0.000 abstract 1
- 238000005917 acylation reaction Methods 0.000 abstract 1
- 125000001309 chloro group Chemical group Cl* 0.000 abstract 1
- LRCIYVMVWAMTKX-UHFFFAOYSA-L chromium(ii) acetate Chemical compound [Cr+2].CC([O-])=O.CC([O-])=O LRCIYVMVWAMTKX-UHFFFAOYSA-L 0.000 abstract 1
- GPNHMOZDMYNCPO-PDUMRIMRSA-N clascoterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@@](C(=O)CO)(OC(=O)CC)[C@@]1(C)CC2 GPNHMOZDMYNCPO-PDUMRIMRSA-N 0.000 abstract 1
- 229940079593 drug Drugs 0.000 abstract 1
- 125000001153 fluoro group Chemical group F* 0.000 abstract 1
- 230000033444 hydroxylation Effects 0.000 abstract 1
- 238000005805 hydroxylation reaction Methods 0.000 abstract 1
- 229960002899 hydroxyprogesterone Drugs 0.000 abstract 1
- 229960003387 progesterone Drugs 0.000 abstract 1
- 239000000186 progesterone Substances 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J7/00—Normal steroids containing carbon, hydrogen, halogen or oxygen substituted in position 17 beta by a chain of two carbon atoms
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J5/00—Normal steroids containing carbon, hydrogen, halogen or oxygen, substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane and substituted in position 21 by only one singly bound oxygen atom, i.e. only one oxygen bound to position 21 by a single bond
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07J—STEROIDS
- C07J75/00—Processes for the preparation of steroids in general
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/913—Aspergillus
-
- Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
- Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
- Y10S435/00—Chemistry: molecular biology and microbiology
- Y10S435/8215—Microorganisms
- Y10S435/911—Microorganisms using fungi
- Y10S435/939—Rhizopus
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Steroid Compounds (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| GB56249/66A GB1158492A (en) | 1966-02-09 | 1966-02-09 | Improvements in Acylated Steroids |
| GB3001868 | 1966-02-09 | ||
| GB571966 | 1966-02-09 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| GB1159490A true GB1159490A (en) | 1969-07-23 |
Family
ID=27254686
Family Applications (2)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB30019/68A Expired GB1159490A (en) | 1966-02-09 | 1966-02-09 | Improvements in Acylated Steroids |
| GB56249/66A Expired GB1158492A (en) | 1966-02-09 | 1966-02-09 | Improvements in Acylated Steroids |
Family Applications After (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| GB56249/66A Expired GB1158492A (en) | 1966-02-09 | 1966-02-09 | Improvements in Acylated Steroids |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US3506694A (enExample) |
| CH (1) | CH487134A (enExample) |
| DK (1) | DK117896B (enExample) |
| FR (2) | FR1513708A (enExample) |
| GB (2) | GB1159490A (enExample) |
| NL (1) | NL151630B (enExample) |
| NO (1) | NO127577B (enExample) |
| SE (1) | SE342239B (enExample) |
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2153357A (en) * | 1984-02-03 | 1985-08-21 | Roussel Uclaf | Production of prednisone derivatives |
| CN107556357A (zh) * | 2017-09-28 | 2018-01-09 | 湖南科瑞生物制药股份有限公司 | 丙酸地泼罗酮的制备方法 |
Families Citing this family (27)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US3856956A (en) * | 1967-02-02 | 1974-12-24 | Boots Pure Drug Co Ltd | 17-acyloxysteroids and their manufacture |
| JP2655190B2 (ja) * | 1989-06-21 | 1997-09-17 | エスエス製薬 株式会社 | コルチコステロイド含有軟膏剤 |
| GB0019172D0 (en) * | 2000-08-05 | 2000-09-27 | Glaxo Group Ltd | Novel compounds |
| US6858596B2 (en) * | 2000-08-05 | 2005-02-22 | Smithkline Beecham Corporation | Formulation containing anti-inflammatory androstane derivative |
| US6777399B2 (en) * | 2000-08-05 | 2004-08-17 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative compositions |
| SI1305329T2 (sl) | 2000-08-05 | 2015-07-31 | Glaxo Group Limited | S-fluorometil ester 6alfa,9alfa-difluoro-17alfa-(2-furanilkarboksil)oksi-11beta-hidroksi- 16alfa-metil-3-okso-androst-1,4-dien-17-karbotiojske kisline kot protivnetno sredstvo |
| US6759398B2 (en) * | 2000-08-05 | 2004-07-06 | Smithkline Beecham Corporation | Anti-inflammatory androstane derivative |
| CA2445839A1 (en) * | 2001-04-30 | 2002-11-07 | Glaxo Group Limited | Anti-inflammatory 17.beta.-carbothioate ester derivatives of androstane with a cyclic ester group in position 17.alpha |
| JP2005500290A (ja) * | 2001-06-12 | 2005-01-06 | グラクソ グループ リミテッド | 抗炎症性の、１７β−カルボチオアートアンドロスタン誘導体である１７α複素環エステル |
| US20050175545A1 (en) * | 2002-02-04 | 2005-08-11 | Keith Biggadike | Formulation for inhalation comprising a glucocorticoid and a beta 2-adrenoreceptor agonist |
| GB0202635D0 (en) * | 2002-02-05 | 2002-03-20 | Glaxo Wellcome Mfg Pte Ltd | Formulation containing novel anti-inflammatory androstane derivative |
| GB2389530B (en) | 2002-06-14 | 2007-01-10 | Cipla Ltd | Pharmaceutical compositions |
| RU2387646C2 (ru) * | 2003-08-29 | 2010-04-27 | Рэнбакси Лабораториз Лимитед | Ингибиторы фосфодиэстеразы типа-iv |
| EP1694655A2 (en) * | 2003-11-26 | 2006-08-30 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
| US20080009535A1 (en) * | 2004-08-30 | 2008-01-10 | Sarala Balachandran | Inhibitors of phosphodiesterase type-IV |
| GB0507165D0 (en) * | 2005-04-08 | 2005-05-18 | Glaxo Group Ltd | Novel crystalline pharmaceutical product |
| EP1934219A1 (en) | 2005-09-16 | 2008-06-25 | Ranbaxy Laboratories Limited | Substituted pyrazolo [3,4-b] pyridines as phosphodiesterase inhibitors |
| CA2626628A1 (en) * | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type iv inhibitors |
| WO2007045979A1 (en) | 2005-10-19 | 2007-04-26 | Ranbaxy Laboratories Limited | Pharmaceutical compositions of muscarinic receptor antagonists |
| GB0615108D0 (en) * | 2006-07-28 | 2006-09-06 | Glaxo Group Ltd | Novel formulations |
| AU2007298549A1 (en) * | 2006-09-22 | 2008-03-27 | Ranbaxy Laboratories Limited | Inhibitors of phosphodiesterase type-IV |
| US20100029728A1 (en) * | 2006-09-22 | 2010-02-04 | Ranbaxy Laboratories Limited | Phosphodiesterase inhibitors |
| US20080207659A1 (en) * | 2007-02-15 | 2008-08-28 | Asit Kumar Chakraborti | Inhibitors of phosphodiesterase type 4 |
| EP2124943A1 (en) * | 2007-03-14 | 2009-12-02 | Ranbaxy Laboratories Limited | Pyrazolo [3, 4-b]pyridine derivatives as phosphodiesterase inhibitors |
| EP2124944B1 (en) * | 2007-03-14 | 2012-02-15 | Ranbaxy Laboratories Limited | Pyrazolo[3,4-b]pyridine derivatives as phosphodiesterase inhibitors |
| EP2111861A1 (en) | 2008-04-21 | 2009-10-28 | Ranbaxy Laboratories Limited | Compositions of phosphodiesterase type IV inhibitors |
| CN102372762B (zh) * | 2010-08-18 | 2012-11-07 | 天津金耀集团有限公司 | 一种孕甾11位β羟基合成的工艺 |
Family Cites Families (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US2923721A (en) * | 1955-12-13 | 1960-02-02 | Lab Francais Chimiotherapie | Method of preparing 3-keto delta1, 4 steroids |
| US2902410A (en) * | 1957-09-26 | 1959-09-01 | Upjohn Co | Process for the 1,2-dehydrogenation of a steroid with septomyxa |
-
1966
- 1966-02-09 GB GB30019/68A patent/GB1159490A/en not_active Expired
- 1966-02-09 GB GB56249/66A patent/GB1158492A/en not_active Expired
-
1967
- 1967-01-25 NO NO00166569A patent/NO127577B/no unknown
- 1967-02-08 FR FR94074A patent/FR1513708A/fr not_active Expired
- 1967-02-08 NL NL676701919A patent/NL151630B/xx not_active IP Right Cessation
- 1967-02-08 FR FR94073A patent/FR6137M/fr not_active Expired
- 1967-02-08 DK DK67267AA patent/DK117896B/da not_active IP Right Cessation
- 1967-02-09 SE SE1837/67A patent/SE342239B/xx unknown
- 1967-02-09 CH CH192067A patent/CH487134A/fr not_active IP Right Cessation
- 1967-11-27 US US685984A patent/US3506694A/en not_active Expired - Lifetime
Cited By (2)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB2153357A (en) * | 1984-02-03 | 1985-08-21 | Roussel Uclaf | Production of prednisone derivatives |
| CN107556357A (zh) * | 2017-09-28 | 2018-01-09 | 湖南科瑞生物制药股份有限公司 | 丙酸地泼罗酮的制备方法 |
Also Published As
| Publication number | Publication date |
|---|---|
| DK117896B (da) | 1970-06-15 |
| FR6137M (enExample) | 1968-06-24 |
| CH487134A (fr) | 1970-03-15 |
| DE1618095B2 (de) | 1975-09-18 |
| NO127577B (enExample) | 1973-07-16 |
| FR1513708A (fr) | 1968-02-16 |
| US3506694A (en) | 1970-04-14 |
| NL6701919A (enExample) | 1967-08-10 |
| SE342239B (enExample) | 1972-01-31 |
| GB1158492A (en) | 1969-07-16 |
| DE1618095A1 (de) | 1971-03-25 |
| NL151630B (nl) | 1976-12-15 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| GB1159490A (en) | Improvements in Acylated Steroids | |
| GB1329387A (en) | Selective microbiological preparation of androst-4-ene 3,17-dione | |
| GB1475795A (en) | Steroid 21-thioesters | |
| GB1445945A (en) | Steroids of the d-homo-pregnane series | |
| GB1127746A (en) | Novel process for preparing unsaturated steroids | |
| GB1571913A (en) | Process for the manufacture of -androstene-3,17-dione derivatives | |
| GB1248938A (en) | Improvements in or relating to gem-difluoro steroids | |
| GB1365469A (en) | Steroids of the d-homopregnane series | |
| GB1508745A (en) | Steroidal(16alpha,17-d)cyclohexenes | |
| US2877240A (en) | 6-fluoro-17beta-hydroxy-17alpha-lower aliphatic hydrocarbon-1, 4-androstadienes and 6-fluoro-17alpha-lower aliphatic hydrocarbon estradiols | |
| US3449495A (en) | Progestational active 17alpha-alkoxy-16-methylene progesterones | |
| US3194832A (en) | 18-nor-d-homo-steroids | |
| IE44308B1 (en) | Process for the manufacture of 5-androsten-17-one derivatives and their use | |
| US4033995A (en) | D-homo steroids | |
| US3763145A (en) | Halogenosteroids | |
| US3665022A (en) | Degradation of side chain in sapogenins | |
| US3126398A (en) | Fluorevated androstenes and process | |
| US2988557A (en) | 16alpha-thiol corticoids and their derivatives | |
| US3126376A (en) | Fluorinated anbrostenes and inter- | |
| GB1130115A (en) | 16-methyl-4-pregnen-3ªß-ol-20-ones and their preparation | |
| GB1180176A (en) | Novel Steroid 21-Esters, their Preparation, and Compositions containing them | |
| GB1280565A (en) | 07-ureido androstane compounds | |
| GB1132061A (en) | 3,17-diketo-steroids | |
| GB1192061A (en) | Steroidal 1,4-Dienes | |
| GB1420892A (en) | Racemic 13beta-ethyl-3-methoxy-8,14-socogona-1,3,5-10,8- tetraen-17beta-ol-14-one and a process for the preparation thereof |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| PS | Patent sealed [section 19, patents act 1949] | ||
| PE | Patent expired |